The findings demonstrated that somatic CNVs persist as quantifiable genomic signatures of ionizing radiation exposure even decades after the event. CNV profiling represents a promising tool for retrospective biodosimetry and long-term health surveillance of exposed populations, reinforcing its potential role in radiological protection and genomic risk assessment frameworks.
Pereira et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: